| LDR | 01185cam a2200289 a 4500 | ||
| 001 | 005336122 | ||
| 003 | MiAaHDL | ||
| 005 | 20221205000000.0 | ||
| 006 | m d | ||
| 007 | cr bn ---auaua | ||
| 008 | 930730s1993 moua b 000 0 eng d | ||
| 035 | ⊔ | ⊔ | ‡a(MiU)990053361220106381 |
| 035 | ⊔ | ⊔ | ‡asdr-miu.990053361220106381 |
| 035 | ⊔ | ⊔ | ‡z(MiU)MIU01000000000000005336122-goog |
| 035 | ⊔ | ⊔ | ‡aMiU-BA.b1669734 ‡bstab ‡c- |
| 035 | ⊔ | ⊔ | ‡a(OCoLC)28032059 |
| 035 | ⊔ | ⊔ | ‡z(MiU)Aleph005336122 |
| 040 | ⊔ | ⊔ | ‡aMiU-BA ‡cMiU-BA |
| 090 | ⊔ | ⊔ | ‡hRA401.A3 W42 |
| 100 | 1 | ⊔ | ‡aWeidenbaum, Murray L. |
| 245 | 1 | 0 | ‡aRestraining medicine prices : ‡bcontrols vs. competition / ‡cby Murray Weidenbaum. |
| 260 | ⊔ | ⊔ | ‡aSt. Louis : ‡bCenter for the Study of American Business, Washington University, ‡cc1993. |
| 300 | ⊔ | ⊔ | ‡a26 p. : ‡bill. ; ‡c23 cm. |
| 500 | ⊔ | ⊔ | ‡a"Policy study, number 16." |
| 500 | ⊔ | ⊔ | ‡aPrepared by the Center for the Study of American Business at Washington University, Saint Louis. |
| 504 | ⊔ | ⊔ | ‡aIncludes bibliographical references (p. 23-26) |
| 538 | ⊔ | ⊔ | ‡aMode of access: Internet. |
| 650 | ⊔ | 0 | ‡aPharmaceutical policy ‡zUnited States ‡xCost control. |
| 710 | 2 | ⊔ | ‡aWashington University (Saint Louis, Mo.). ‡bCenter for the Study of American Business. |
| 899 | ⊔ | ⊔ | ‡a35128001418795 |
| CID | ⊔ | ⊔ | ‡a005336122 |
| DAT | 0 | ⊔ | ‡a19930802064910.0 ‡b20221205000000.0 |
| DAT | 1 | ⊔ | ‡a20221206061329.0 ‡b2024-03-06T18:30:38Z |
| CAT | ⊔ | ⊔ | ‡aSDR-MIU ‡cmiu ‡dALMA ‡lprepare.pl-004-008 |
| FMT | ⊔ | ⊔ | ‡aBK |
| HOL | ⊔ | ⊔ | ‡0sdr-miu.990053361220106381 ‡aMiU ‡bSDR ‡cUMBUS ‡f005336122 ‡pmdp.35128001418795 ‡sMIU ‡1990053361220106381 |
| 974 | ⊔ | ⊔ | ‡bMIU ‡cUMBUS ‡d20240306 ‡sgoogle ‡umdp.35128001418795 ‡y1993 ‡ric ‡qbib ‡tUS bib date1 >= 1929 |